IDEAS home Printed from https://ideas.repec.org/d/hpucdus.html
 

Publications

by members of

Division of Health Policy and Management
Department of Public Health Sciences
School of Medecine
University of California-Davis
Davis, California (United States)

These are publications listed in RePEc written by members of the above institution who are registered with the RePEc Author Service. Thus this compiles the works all those currently affiliated with this institution, not those affilated at the time of publication. List of registered members. Register yourself. Citation analysis. This page is updated in the first days of each month.
| Journal articles | Chapters |

Journal articles

2019

  1. Sandjar Djalalov & Jaclyn Beca & Emmanuel M. Ewara & Jeffrey S. Hoch, 2019. "A Comparison of Different Analysis Methods for Reconstructed Survival Data to Inform Cost‑Effectiveness Analysis," PharmacoEconomics, Springer, vol. 37(12), pages 1525-1536, December.

2018

  1. Jaclyn Beca & Don Husereau & Kelvin K. W. Chan & Neil Hawkins & Jeffrey S. Hoch, 2018. "Oncology Modeling for Fun and Profit! Key Steps for Busy Analysts in Health Technology Assessment," PharmacoEconomics, Springer, vol. 36(1), pages 7-15, January.
  2. Malek B. Hannouf & Eric Winquist & Salaheddin M. Mahmud & Muriel Brackstone & Sisira Sarma & George Rodrigues & Peter K. Rogan & Jeffrey S. Hoch & Gregory S. Zaric, 2018. "The Potential Clinical and Economic Value of Primary Tumour Identification in Metastatic Cancer of Unknown Primary Tumour: A Population-Based Retrospective Matched Cohort Study," PharmacoEconomics - Open, Springer, vol. 2(3), pages 255-270, September.
  3. David G. T. Whitehurst & Nicholas R. Latimer & Aura Kagan & Rebecca Palmer & Nina Simmons-Mackie & J. Charles Victor & Jeffrey S. Hoch, 2018. "Developing Accessible, Pictorial Versions of Health-Related Quality-of-Life Instruments Suitable for Economic Evaluation: A Report of Preliminary Studies Conducted in Canada and the United Kingdom," PharmacoEconomics - Open, Springer, vol. 2(3), pages 225-231, September.

2017

  1. S Lucas Goede & Linda Rabeneck & Marjolein van Ballegooijen & Ann G Zauber & Lawrence F Paszat & Jeffrey S Hoch & Jean H E Yong & Sonja Kroep & Jill Tinmouth & Iris Lansdorp-Vogelaar, 2017. "Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening," PLOS ONE, Public Library of Science, vol. 12(3), pages 1-15, March.
  2. Kavisha Jayasundara & Murray Krahn & Muhammad Mamdani & Jeffrey S. Hoch & Paul Grootendorst, 2017. "Differences in Incremental Cost-Effectiveness Ratios for Common Versus Rare Conditions: A Case from Oncology," PharmacoEconomics - Open, Springer, vol. 1(3), pages 167-173, September.
  3. Lisa Masucci & Jaclyn Beca & Mona Sabharwal & Jeffrey S. Hoch, 2017. "Methodological Issues in Economic Evaluations Submitted to the Pan-Canadian Oncology Drug Review (pCODR)," PharmacoEconomics - Open, Springer, vol. 1(4), pages 255-263, December.

2016

  1. Carolyn S Dewa & Lucy Trojanowski & Sietske J Tamminga & Jolie Ringash & Maurene McQuestion & Jeffrey S Hoch, 2016. "Advice about Work-Related Issues to Peers and Employers from Head and Neck Cancer Survivors," PLOS ONE, Public Library of Science, vol. 11(4), pages 1-13, April.
  2. Amy Tawfik & Walter P. Wodchis & Petros Pechlivanoglou & Jeffrey Hoch & Don Husereau & Murray Krahn, 2016. "Using Phase-Based Costing of Real-World Data to Inform Decision–Analytic Models for Atrial Fibrillation," Applied Health Economics and Health Policy, Springer, vol. 14(3), pages 313-322, June.

2015

  1. Wanrudee Isaranuwatchai & Maureen Markle-Reid & Jeffrey Hoch, 2015. "Adjusting for Baseline Covariates in Net Benefit Regression: How You Adjust Matters," PharmacoEconomics, Springer, vol. 33(10), pages 1083-1090, October.
  2. Jeffrey Hoch & Jaclyn Beca & Mona Sabharwal & Scott Livingstone & Anthony Fields, 2015. "Does it Matter Whether Canada’s Separate Health Technology Assessment Process for Cancer Drugs has an Economic Rationale?," PharmacoEconomics, Springer, vol. 33(8), pages 879-882, August.

2014

  1. Regier, Dean A. & Bentley, Colene & Mitton, Craig & Bryan, Stirling & Burgess, Michael M. & Chesney, Ellen & Coldman, Andy & Gibson, Jennifer & Hoch, Jeffrey & Rahman, Syed & Sabharwal, Mona & Sawka, , 2014. "Public engagement in priority-setting: Results from a pan-Canadian survey of decision-makers in cancer control," Social Science & Medicine, Elsevier, vol. 122(C), pages 130-139.
  2. Sandjar Djalalov & Linda Rabeneck & George Tomlinson & Karen E. Bremner & Robert Hilsden & Jeffrey S. Hoch, 2014. "A Review and Meta-analysis of Colorectal Cancer Utilities," Medical Decision Making, , vol. 34(6), pages 809-818, August.

2013

  1. Jean Yong & Jaclyn Beca & Jeffrey Hoch, 2013. "The Evaluation and Use of Economic Evidence to Inform Cancer Drug Reimbursement Decisions in Canada," PharmacoEconomics, Springer, vol. 31(3), pages 229-236, March.

2008

  1. Hoch, Jeffrey S. & Blume, Jeffrey D., 2008. "Measuring and illustrating statistical evidence in a cost-effectiveness analysis," Journal of Health Economics, Elsevier, vol. 27(2), pages 476-495, March.

2007

  1. Jeffrey Hoch & Carolyn Dewa, 2007. "Lessons from Trial-Based Cost-Effectiveness Analyses of Mental Health Interventions," PharmacoEconomics, Springer, vol. 25(10), pages 807-816, October.

2004

  1. Andrew R. Willan & Andrew H. Briggs & Jeffrey S. Hoch, 2004. "Regression methods for covariate adjustment and subgroup analysis for non‐censored cost‐effectiveness data," Health Economics, John Wiley & Sons, Ltd., vol. 13(5), pages 461-475, May.

2002

  1. Jeffrey S. Hoch & Andrew H. Briggs & Andrew R. Willan, 2002. "Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost‐effectiveness analysis," Health Economics, John Wiley & Sons, Ltd., vol. 11(5), pages 415-430, July.

Chapters

2021

  1. Carolyn S. Dewa & Jeffrey S. Hoch, 2021. "Labs and cases in health insurance and cost-effectiveness analyses to enhance active learning experiences in an introductory healtheconomics course for students in health professions," Chapters, in: Maia Platt & Allen C. Goodman (ed.), Handbook on Teaching Health Economics, chapter 4, pages 44-60, Edward Elgar Publishing.
  2. Jeffrey S. Hoch & Carolyn S. Dewa, 2021. "Using net benefit regression to teach cost-effectiveness analysis with a dataset," Chapters, in: Maia Platt & Allen C. Goodman (ed.), Handbook on Teaching Health Economics, chapter 6, pages 77-87, Edward Elgar Publishing.

2018

  1. Jeffrey S. Hoch & Pierre Chaussé, 2018. "Econometric Considerations When Using the Net Benefit Regression Framework to Conduct Cost-effectiveness Analysis," Contributions to Economic Analysis, in: Health Econometrics, volume 127, pages 119-143, Emerald Group Publishing Limited.

2013

  1. Jeffrey S. Hoch, 2013. "Improving the Efficiency of Cost-effectiveness Analysis to Inform Policy Decisions in the Real World: Lessons from the Pharmacoeconomics Research Unit at Cancer Care Ontario," International Series in Operations Research & Management Science, in: Gregory S. Zaric (ed.), Operations Research and Health Care Policy, edition 127, chapter 0, pages 399-416, Springer.

IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.